PJA2
Basic information
Region (hg38): 5:109334713-109409974
Previous symbols: [ "RNF131" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PJA2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 34 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 34 | 0 | 0 |
Variants in PJA2
This is a list of pathogenic ClinVar variants found in the PJA2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-109337266-G-A | not specified | Uncertain significance (Nov 15, 2024) | ||
5-109337295-G-A | not specified | Uncertain significance (Jun 07, 2024) | ||
5-109344285-T-C | not specified | Uncertain significance (Oct 29, 2024) | ||
5-109344287-G-C | not specified | Uncertain significance (Apr 08, 2023) | ||
5-109344295-T-G | not specified | Uncertain significance (Nov 13, 2024) | ||
5-109355935-G-A | not specified | Uncertain significance (Feb 13, 2023) | ||
5-109356003-C-G | not specified | Uncertain significance (Nov 17, 2022) | ||
5-109362916-G-A | not specified | Uncertain significance (Jun 28, 2022) | ||
5-109362994-T-C | not specified | Uncertain significance (May 27, 2022) | ||
5-109368595-C-T | not specified | Uncertain significance (Oct 29, 2024) | ||
5-109368603-C-T | not specified | Uncertain significance (Feb 13, 2024) | ||
5-109368607-T-C | not specified | Uncertain significance (Sep 11, 2024) | ||
5-109368635-A-T | not specified | Uncertain significance (Jan 02, 2024) | ||
5-109368693-C-T | not specified | Uncertain significance (Dec 06, 2022) | ||
5-109368709-G-A | not specified | Uncertain significance (Mar 30, 2024) | ||
5-109378243-C-T | not specified | Uncertain significance (Aug 16, 2022) | ||
5-109378267-A-G | not specified | Uncertain significance (May 28, 2024) | ||
5-109378270-T-C | not specified | Uncertain significance (Aug 26, 2024) | ||
5-109378292-C-G | not specified | Uncertain significance (Aug 27, 2024) | ||
5-109378375-T-C | not specified | Uncertain significance (Nov 10, 2022) | ||
5-109378406-A-C | not specified | Uncertain significance (May 20, 2024) | ||
5-109378451-A-G | not specified | Uncertain significance (May 18, 2022) | ||
5-109378457-G-C | not specified | Uncertain significance (May 18, 2023) | ||
5-109378474-G-A | not specified | Uncertain significance (Oct 19, 2024) | ||
5-109378496-T-C | not specified | Uncertain significance (Sep 14, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PJA2 | protein_coding | protein_coding | ENST00000361189 | 9 | 75286 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0237 | 0.976 | 125729 | 0 | 15 | 125744 | 0.0000596 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.426 | 339 | 362 | 0.937 | 0.0000165 | 4709 |
Missense in Polyphen | 38 | 87.29 | 0.43533 | 1193 | ||
Synonymous | -0.982 | 138 | 124 | 1.11 | 0.00000568 | 1274 |
Loss of Function | 3.69 | 9 | 31.3 | 0.288 | 0.00000139 | 410 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000909 | 0.0000909 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000356 | 0.0000352 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000166 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Has E2-dependent E3 ubiquitin-protein ligase activity. Responsible for ubiquitination of cAMP-dependent protein kinase type I and type II-alpha/beta regulatory subunits and for targeting them for proteasomal degradation. Essential for PKA- mediated long-term memory processes. Through the ubiquitination of MFHAS1, positively regulates the TLR2 signaling pathway that leads to the activation of the downstream p38 and JNK MAP kinases and promotes the polarization of macrophages toward the pro- inflammatory M1 phenotype (PubMed:28471450). {ECO:0000269|PubMed:12036302, ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:28471450}.;
- Pathway
- Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
(Consensus)
Recessive Scores
- pRec
- 0.0951
Intolerance Scores
- loftool
- 0.489
- rvis_EVS
- -0.13
- rvis_percentile_EVS
- 43.98
Haploinsufficiency Scores
- pHI
- 0.324
- hipred
- Y
- hipred_score
- 0.583
- ghis
- 0.558
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.940
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pja2
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; skeleton phenotype; immune system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- pja2
- Affected structure
- post-vent region
- Phenotype tag
- abnormal
- Phenotype quality
- deformed
Gene ontology
- Biological process
- inflammatory response;long-term memory;regulation of protein kinase A signaling;protein ubiquitination;positive regulation of toll-like receptor 2 signaling pathway;hippo signaling;regulation of macrophage activation;innate immune response;positive regulation of JNK cascade;positive regulation of p38MAPK cascade
- Cellular component
- Golgi membrane;cytoplasm;endoplasmic reticulum membrane;plasma membrane;postsynaptic density;cell junction;intermediate filament cytoskeleton;postsynaptic membrane
- Molecular function
- ubiquitin-protein transferase activity;protein binding;protein kinase A catalytic subunit binding;protein kinase A regulatory subunit binding;metal ion binding;ubiquitin protein ligase activity